When did BI, Bologna, and MDA(?) acquire KEVETRIN to do their preclinical work that confirmed their decision to proceed to clinical trials?  Am I right in thinking these org. have already finished their preclinicals?  If so, then there could be any number of unannounced other university/big pharma partnerships running preclinicals now on other KEVETRIN cocktails to determine if they are worth taking to clinical trials?

Could KEVETRIN already be further along for additional studies than the handful of trials we know of today?